Our Pricing

How to Begin Your Mounjaro Treatment Journey in the UK

Published on: June 03, 2026

If you're considering starting Mounjaro UK online pharmacy treatment, understanding the complete journey from eligibility assessment to your first injection is essential. At Cured Pharmacy, our UK-registered clinical team guides you through every step, from a free 3-minute consultation to discreet delivery of genuine UK-licensed Mounjaro pens from £124.99. This comprehensive guide explains exactly what to expect when beginning your tirzepatide treatment journey.

Understanding Mounjaro: How Tirzepatide Works for Weight Loss

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike traditional weight loss medications that work through a single pathway, tirzepatide simultaneously activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, creating a more comprehensive metabolic response.

This dual-action mechanism helps regulate appetite, slow gastric emptying, and improve insulin sensitivity. In the landmark SURMOUNT-1 trial, participants receiving the 15mg maintenance dose achieved an average body weight reduction of 22.5% over 72 weeks — substantially higher than single-pathway alternatives [1]. The medication works by mimicking natural hormones that signal fullness to your brain, helping you feel satisfied with smaller portions whilst supporting sustainable lifestyle changes.

Tirzepatide is administered as a once-weekly subcutaneous injection using the convenient KwikPen device. The treatment follows a carefully structured dose escalation schedule, starting at 2.5mg and gradually increasing every four weeks to minimise gastrointestinal side effects whilst optimising efficacy. All Mounjaro prescriptions at Cured Pharmacy are issued following clinical assessment by UK-registered prescribers, ensuring the treatment is appropriate for your individual health profile.

Am I Eligible for Mounjaro? UK Prescribing Criteria Explained

Mounjaro is a prescription-only medication in the UK, and eligibility is determined by MHRA-approved prescribing guidelines. Generally, UK prescribers may consider tirzepatide for adults with a body mass index (BMI) of 30 kg/m² or above, or a BMI of 27 kg/m² or above with at least one weight-related health condition such as hypertension, type 2 diabetes, or dyslipidaemia [2].

During your free online consultation at Cured Pharmacy, our UK clinical team will assess your complete medical history, current medications, and weight management goals. Certain conditions may make Mounjaro unsuitable, including a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or pregnancy and breastfeeding. Your prescriber will also review any medications you're currently taking to identify potential interactions.

The consultation process typically takes under three minutes and involves answering detailed health questions through our secure online platform. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and the clinical team review every assessment individually to ensure patient safety. If Mounjaro isn't suitable for you, our prescribers may recommend alternative weight management treatments such as Wegovy or Saxenda, both available through the same streamlined consultation process.

Medical Conditions That May Affect Eligibility

Your prescriber will carefully evaluate pre-existing conditions including diabetic retinopathy, pancreatitis history, renal impairment, and cardiovascular disease. Whilst Mounjaro has demonstrated cardiovascular benefits in clinical trials, individual risk assessment is essential [3]. If you have type 2 diabetes and are currently taking insulin or sulfonylureas, your prescriber may need to adjust these medications to prevent hypoglycaemia when starting tirzepatide. Transparency during your consultation ensures safe, effective treatment tailored to your health needs.

The Cured Pharmacy Consultation Process: What to Expect

Starting Mounjaro through Cured Pharmacy begins with our straightforward online consultation. After selecting 'Start Assessment' on the Mounjaro product page, you'll complete a comprehensive medical questionnaire covering your weight history, current health conditions, medications, allergies, and lifestyle factors. The questionnaire is designed to gather all information a UK prescriber needs to make an informed clinical decision.

Once submitted, your assessment is reviewed by a UK-registered prescriber, typically within 24 hours on working days. If approved, your prescription is issued electronically and sent directly to our GPhC-registered pharmacy (9012511) for dispensing. You'll receive email confirmation at each stage, including prescription approval, dispatch notification with tracking details, and delivery updates. All packaging is 100% discreet with no external markings indicating contents.

If your prescriber requires additional information or determines Mounjaro isn't currently suitable, they'll contact you directly via secure messaging or telephone. There's no obligation to proceed, and our clinical team is available on (+44) 116 4646009 during working hours to answer questions about your assessment. Pricing is transparent from the outset — you'll see the exact cost of £135.00 before beginning your consultation, with no hidden fees or surprise charges at checkout.

Prescription Approval Timeframes

Most consultations are reviewed within 24 hours on working days, though complex medical histories may require additional review time. Once approved, prescriptions are typically dispensed and dispatched within 24-48 hours via tracked courier service. If you need your medication urgently, contact our pharmacy team after submitting your consultation to discuss expedited options where clinically appropriate.

Starting Mounjaro: Your First Injection and Dose Escalation Schedule

All patients begin Mounjaro treatment at the 2.5mg starting dose, administered once weekly via subcutaneous injection. This initial dose is not intended for weight loss but serves as a tolerability dose, allowing your body to adjust to tirzepatide whilst minimising gastrointestinal side effects such as nausea, vomiting, and diarrhoea [1]. You'll remain on 2.5mg for four weeks before escalating to the next dose.

The standard dose escalation schedule follows this pattern: 2.5mg for 4 weeks, then 5mg for 4 weeks, then 7.5mg for 4 weeks, then 10mg for 4 weeks, then 12.5mg for 4 weeks, with a maximum maintenance dose of 15mg. Your prescriber will determine your optimal maintenance dose based on your weight loss response and tolerability. Some patients achieve their goals at lower maintenance doses, whilst others benefit from the full 15mg dose [4].

Each Mounjaro KwikPen is pre-filled and designed for single-patient use over four weeks (four weekly injections). The pen features a simple click mechanism and hidden needle for ease of use. Your first prescription will include detailed injection instructions, and Cured Pharmacy provides supplementary guidance materials via email. Most patients choose to inject into the abdomen, thigh, or upper arm, rotating injection sites weekly to prevent lipodystrophy. The injection takes less than a minute and can be administered at any time of day, with or without food.

What to Expect in Your First Month: Realistic Timelines and Side Effects

During your first four weeks on the 2.5mg starting dose, weight loss is typically modest — most patients lose 1-3 kg as their body adjusts to the medication. The most significant weight reduction occurs after reaching higher maintenance doses, usually from month 3 onwards. In clinical trials, average weight loss at 72 weeks was 22.5% of initial body weight on the 15mg dose, but individual results vary considerably based on adherence, diet, physical activity, and metabolic factors [1].

Gastrointestinal side effects are most common during the first few weeks and with each dose escalation. Approximately 20-30% of patients experience mild to moderate nausea, though this typically subsides within days as your body adapts [4]. Eating smaller, more frequent meals, avoiding high-fat foods, and staying well-hydrated can help manage these symptoms. If side effects become severe or persistent, contact your prescriber — they may recommend staying at your current dose longer before escalating, or adjusting your treatment plan.

Other common side effects reported in clinical trials include constipation, diarrhoea, decreased appetite, fatigue, and injection site reactions. Serious side effects are rare but require immediate medical attention, including signs of pancreatitis (severe abdominal pain radiating to the back), severe allergic reactions, vision changes, or symptoms of thyroid tumours (neck lump, difficulty swallowing, persistent hoarseness). Your prescriber will discuss warning signs during your consultation, and you should always read the patient information leaflet provided with your medication.

Managing Common Side Effects

To minimise nausea, try eating slowly, choosing bland foods, and avoiding lying down immediately after meals. Ginger tea and small sips of cold water between meals may help. For constipation, increase dietary fibre gradually, drink at least 2 litres of water daily, and consider gentle physical activity like walking. If symptoms persist beyond two weeks or significantly impact your quality of life, consult your prescriber about symptomatic treatments or dose adjustment strategies.

Comparing Mounjaro to Other Weight Loss Treatments Available at Cured Pharmacy

Whilst Mounjaro has demonstrated superior weight loss outcomes in head-to-head trials, it's not the only effective option available through Cured Pharmacy. Wegovy contains semaglutide, a single GLP-1 receptor agonist that achieved an average 14.9% weight reduction over 68 weeks in the STEP-1 trial [2]. Wegovy follows a similar once-weekly injection schedule and may be more suitable for patients with specific contraindications to tirzepatide or those seeking a lower-cost alternative.

Saxenda contains liraglutide, an earlier-generation GLP-1 agonist administered as a daily injection. Whilst requiring more frequent dosing, Saxenda has an established safety profile spanning over a decade of clinical use and may be preferred by patients who want more flexible dose titration. Orlistat-based treatments including Xenical, Alli, and Orlos work through a completely different mechanism — blocking fat absorption in the intestine — and are suitable for patients who prefer oral medications or have contraindications to GLP-1 therapies.

Your UK prescriber will discuss all suitable options during your consultation, considering your medical history, weight loss goals, lifestyle preferences, and budget. All prescription weight loss medications available at Cured Pharmacy are MHRA-licensed, dispensed from our UK-registered pharmacy, and supported by the same clinical oversight and patient care standards. Switching between treatments is possible if your initial choice doesn't suit you, subject to prescriber approval and reassessment.

Injectable vs Oral Weight Loss Medications

Injectable GLP-1 treatments like Mounjaro, Wegovy, and Saxenda generally produce greater weight loss than oral alternatives, but require comfort with self-injection and subcutaneous administration. Oral options like Orlistat are taken with meals and work locally in the digestive system without systemic absorption, making them suitable for patients with certain cardiovascular or endocrine conditions. Wegovy oral tablets (semaglutide pill) are now available for pre-order at Cured Pharmacy, offering the efficacy of semaglutide in a daily tablet format for patients who prefer oral administration.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., McGowan, B. M., Rosenstock, J., Tran, M. T. D., Wadden, T. A., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R. F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Sattar, N., McGuire, D. K., Pavo, I., Weerakkody, G. J., Nishiyama, H., Wiese, R. J., & Zoungas, S. (2022). Tirzepatide cardiovascular event risk assessment: a pre-specified meta-analysis. Nature Medicine, 28(3), 591–598. https://doi.org/10.1038/s41591-022-01707-4 [accessed 13 August 2026]
4. Electronic Medicines Compendium. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics (SmPC). Retrieved from https://www.medicines.org.uk/emc/product/14881/smpc [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual results may vary, and weight loss outcomes depend on adherence to treatment, diet, exercise, and metabolic factors. Mounjaro is not suitable for everyone — eligibility is determined through clinical consultation.